Form 4: Axogen Director John Johnson Reports Stock Vesting
SEC Form 4 Filing
Director John Johnson reports the vesting of 11,904 restricted stock units of Axogen, Inc. on September 1, 2024.
Summary
- John Johnson, a director of Axogen, Inc., reported the vesting of 11,904 restricted stock units on September 1, 2024.
- Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- The vesting is related to an annual equity grant for service as a Director on the Axogen, Inc. Board of Directors.
- The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date.
Sentiment
Score: 5
Explanation: This is a routine filing related to director compensation and doesn't indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The vesting of stock units could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 09/01/2024 | Date of transaction: vesting of restricted stock units. |
| 09/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.